1. Including Traditional Chinese Medicine Diagnoses in ICD-11 May Not Advance the Evaluation of Traditional Chinese Medicine Therapies

   • Stewart Geary

   Commentary 21 August 2019 Pages: 369 - 371

2. ICD-11: Impact on Traditional Chinese Medicine and World Healthcare Systems

   • Wai Ching Lam
   • Aiping Lyu
   • Zhaoxiang Bian

   Current Opinion 26 July 2019 Pages: 373 - 377

3. Design and Analysis of Biosimilar Switching Studies

   • Shein-Chung Chow
   • Sang Joon Lee

   Leading Article 20 August 2019 Pages: 379 - 388

4. Liver Test Monitoring: Real-World Compliance for Drugs with Monitoring Requirements at 2-Week Intervals or More Frequently

   • Marsha A. Wilcox
   • Jill Hardin
   • Erica A. Voss

   Short Communication Open access 08 August 2019 Pages: 389 - 394

   

5. Effectiveness of Risk Minimization Measures to Prevent Pregnancy Exposure to Mycophenolate-Containing Medicines in Europe

   • Terri Madison
   • Barbara Donner
   • Giuseppe Alvaro

   Original Research Article 28 September 2019 Pages: 395 - 406

   

6. Ethnicity-Specific Drug Safety Data in European Medicines Agency Registration Dossiers, European Public Assessment Reports, and European and Singapore Drug Labels: Lost in Translation?

   • Marc Maliepaard
   • Anne C. Taams
   • Yang Yu

   Original Research Article Open access 05 September 2019 Pages: 407 - 416

   

7. Evaluation of the Implementation of Additional Risk Minimization Activities in Europe, the USA, and Japan

   • Yuka Yasuoka
   • Masayuki Kaneko
   • Mamoru Narukawa

   Original Research Article 21 September 2019 Pages: 417 - 424

   

8. Forum

   Update 06 September 2019 Pages: 425 - 438

9. Major Pharmaceutical Conferences and Courses

   Update 06 September 2019 Pages: 439 - 440